Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 11 1996, 640-644, Vol 3, No. 6
RM Grant, EM Piwowar, E Katongole-Mbidde, W Muzawalu, S Rugera, J Abima, SL Stramer, P Kataaha and B Jackson
The accuracy and acceptability of saliva human immunodeficiency virus type
1 (HIV-1) antibody testing were compared with serum testing in a study of
paired specimens from HIV-1-seropositive and HIV-1- seronegative Ugandan
adults attending a clinic for sexually transmitted diseases. Saliva
collection was performed with the Omni-sal device (Saliva Diagnostic
Systems, Vancouver, Wash.), and antibody testing was performed by a rapid
filter paper assay (Test-Pack; Abbott Laboratories, Abbott Park, Ill.).
Relative to serum testing, the sensitivity of saliva testing was 95% (195
of 205) and the specificity was 99% (295 of 297). The sensitivity of saliva
testing was higher for patients with elevated levels of beta-2
microglobulin in sera and greater numbers of HIV-1-related symptoms. Pre-
and poststudy interviews indicated that saliva testing did not foster
inordinate fears of saliva exposure. The development of saliva tests that
are inexpensive and do not require electricity is needed.
Copyright © 1996 by the American Society for Microbiology. All rights reserved.
Comparison of saliva and serum for human immunodeficiency virus type 1 antibody testing in Uganda using a rapid recombinant assay
University of California, San Francisco, USA. rgrant@hsa.uscf.edu
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |